Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Stoehr

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Clinical and Translational Science|March 26, 2021
A population pharmacodynamic Markov mixed-effects model for determining remimazolam-induced sedation when co-administered with fentanyl in procedural sedationJie Zhou, Laura Curd, Lauren R L Lohmer, et al.
Anaesthesia, Critical Care & Pain Medicine|April 2, 2025
A phase 2 open-label pilot study of Remimazolam for sedation in critically ill patientsNicolas Grillot, Mickaël Vourc'h, Yannick Hourmant, et al.
British Journal of Anaesthesia|May 1, 2025
Development and analysis of a remimazolam pharmacokinetics and pharmacodynamics model with proposed dosing and concentrations for anaesthesia and sedationDouglas J Eleveld, Pieter J Colin, Johannes P Van den Berg, et al.
Journal of Clinical Anesthesia|June 26, 2020
Population pharmacokinetic/pharmacodynamic modeling for remimazolam in the induction and maintenance of general anesthesia in healthy subjects and in surgical subjectsJie Zhou, Cathrine Leonowens, Vijay D Ivaturi, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Clinical and Translational Science|March 26, 2021
A population pharmacodynamic Markov mixed-effects model for determining remimazolam-induced sedation when co-administered with fentanyl in procedural sedationJie Zhou, Laura Curd, Lauren R L Lohmer, et al.
Anaesthesia, Critical Care & Pain Medicine|April 2, 2025
A phase 2 open-label pilot study of Remimazolam for sedation in critically ill patientsNicolas Grillot, Mickaël Vourc'h, Yannick Hourmant, et al.
British Journal of Anaesthesia|May 1, 2025
Development and analysis of a remimazolam pharmacokinetics and pharmacodynamics model with proposed dosing and concentrations for anaesthesia and sedationDouglas J Eleveld, Pieter J Colin, Johannes P Van den Berg, et al.
Journal of Clinical Anesthesia|June 26, 2020
Population pharmacokinetic/pharmacodynamic modeling for remimazolam in the induction and maintenance of general anesthesia in healthy subjects and in surgical subjectsJie Zhou, Cathrine Leonowens, Vijay D Ivaturi, et al.
Pageof 2